Tecovirimat
Tecovirimat is an antiviral agent that inhibits the VP37 protein of orthopoxviruses, blocking the wrapping of intracellular mature virions and thereby preventing efficient spread of the virus between cells and to extracellular environments. It is approved for the treatment of smallpox and has been used under emergency authorization for mpox (monkeypox), representing a key countermeasure in orthopoxvirus preparedness. Its highly selective mechanism targets a viral protein with no human homolog, providing a favorable safety profile.
Moleküler Ağırlık
376,3000 g/mol
LogP
2,60
TPSA
66,50 Ų
Lipinski RO5
Geçer
Pharmacokinetics (PK)
Pharmacodynamics (PD)
2D Yapı
Cite this structure
Embed this structure
SMILES
O=C(NN1C(=O)[C@@H]2[C@@H]3C=C[C@@H]([C@H]4C[C@@H]34)[C@@H]2C1=O)c1ccc(C(F)(F)F)cc1
InChI
InChI=1S/C19H15F3N2O3/c20-19(21,22)9-3-1-8(2-4-9)16(25)23-24-17(26)14-10-5-6-11(13-7-12(10)13)15(14)18(24)27/h1-6,10-15H,7H2,(H,23,25)/t10-,11+,12+,13-,14-,15+
Molecular Formula
C19H15F3N2O3
HBD / HBA
1 / 6
Döndürülebilir Bağlar
1
Ağır Atomlar
27
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
Tecovirimat is an antiviral agent that inhibits the VP37 protein of orthopoxviruses, blocking the wrapping of intracellular mature virions and thereby preventing efficient spread of the virus between cells and to extracellular environments. It is approved for the treatment of smallpox and has been used under emergency authorization for mpox (monkeypox), representing a key countermeasure in orthopoxvirus preparedness. Its highly selective mechanism targets a viral protein with no human homolog, providing a favorable safety profile.
Yes, Tecovirimat is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1257073. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 16124688. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="tecovirimat"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/tecovirimat/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/tecovirimat/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/tecovirimat/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="tecovirimat"></drugfyi-drug>